Financial statements Norsa Pharma
Cash flow statement of Norsa Pharma
Company age:
Age:
11 y. 12 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of NORSA PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|
| Net cash from operating expenses | - | - | - | - | - | 1 681 043,92 | 6 054 709,27 |
| Net cash flow from investing activities | - | - | - | - | - | -304 780,43 | -482 706,18 |
| Net cash flow from financial activities | - | - | - | - | - | -278 107,01 | -1 131 000,00 |
| Total net cash flow | - | - | - | - | - | 1 098 156,48 | 4 441 003,09 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.